Quick Dispatch:
Your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month ships.
Need Help?
Questions about dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month in your area.
Dr. Reddy's Laboratories Wins Health Canada Nod for Generic Semaglutide Injection
25.90
Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment
27.62
GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes
29.62
Glucagon-like peptide-1 receptor agonists (GLP-1 RA): dosing, dose
23.77
Trends in the Development of GLP-1 Receptor Agonists
27.59
Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review
26.15
GLP-1 Agonists - What is it?
26.27
